Olivier Riant

Title: Olivier Riant: Innovator in Anti-Cancer Research

Introduction

Olivier Riant is a notable inventor based in Brussels, Belgium. He has made significant contributions to the field of anti-cancer research through his innovative work on phenazine derivatives. His research focuses on developing compounds that can serve as effective anti-angiogenic and anti-tumor agents.

Latest Patents

Olivier Riant holds a patent for "Substituted 2,3-dihydro-1H-benzo[a]pyrano[2,3-c]phenazines as anti-angiogenic and anti-cancer agents." This patent includes novel phenazine derivatives that can be utilized in the treatment of cancer. The compounds disclosed in his patent are particularly valuable for their potential use in combating tumor growth and angiogenesis.

Career Highlights

Throughout his career, Olivier Riant has worked with prestigious institutions such as Université Catholique de Louvain and Université Libre de Bruxelles. His academic background and research endeavors have positioned him as a key figure in the field of cancer research.

Collaborations

Olivier Riant has collaborated with notable colleagues, including Olivier Feron and Robert Kiss. These partnerships have further enhanced his research and contributed to advancements in anti-cancer therapies.

Conclusion

Olivier Riant's innovative work in developing anti-cancer agents showcases his commitment to advancing medical science. His contributions are vital in the ongoing fight against cancer, and his research continues to inspire future innovations in the field.